FAP and myocardial disorder: Owing to the identification of fibroblast activation protein (FAP) as a promising target for the treatment of solid tumors [205], engineered CAR-T cells that recognize FAP also significantly reduce cardiac fibrosis and improve heart function in the treatment of myocardial diseases [206].